Yingcheng Wu

2.7k total citations · 1 hit paper
32 papers, 987 citations indexed

About

Yingcheng Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yingcheng Wu has authored 32 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Immunology. Recurrent topics in Yingcheng Wu's work include RNA modifications and cancer (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (6 papers). Yingcheng Wu is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immunotherapy and Immune Responses (6 papers). Yingcheng Wu collaborates with scholars based in China, Ethiopia and United States. Yingcheng Wu's co-authors include Qiang Gao, Jia Fan, Maorong Jiang, Renfang Mao, Yihui Fan, Zijian Yang, Hui Shi, Shu Zhang, Xuelian Ren and Shangli Cai and has published in prestigious journals such as PLoS ONE, Hepatology and International Journal of Cancer.

In The Last Decade

Yingcheng Wu

31 papers receiving 984 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma

2023 354 citations Zijian Yang, Cong Yan et al. Nature Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yingcheng Wu China	15	523	344	314	195	179	32	987
Birte Hellwig Germany	13	581 1.1×	360 1.0×	273 0.9×	175 0.9×	273 1.5×	20	1.1k
Rui Xu China	20	659 1.3×	243 0.7×	385 1.2×	200 1.0×	152 0.8×	59	1.1k
Weitao Shen China	12	797 1.5×	260 0.8×	482 1.5×	177 0.9×	350 2.0×	18	1.3k
Yee Chan‐Li United States	17	383 0.7×	153 0.4×	205 0.7×	407 2.1×	192 1.1×	34	1.1k
Akira Morimiya United States	11	628 1.2×	504 1.5×	343 1.1×	97 0.5×	159 0.9×	16	1.1k
Jeremy A. Meier United States	15	541 1.0×	385 1.1×	185 0.6×	327 1.7×	84 0.5×	24	1.1k
Haizeng Zhang China	12	316 0.6×	266 0.8×	152 0.5×	102 0.5×	128 0.7×	42	752
Sandeep Dhayade United Kingdom	13	576 1.1×	165 0.5×	251 0.8×	99 0.5×	56 0.3×	17	893
Mélanie Lambert France	14	456 0.9×	148 0.4×	126 0.4×	123 0.6×	126 0.7×	28	802
Hong Zheng China	21	1.1k 2.2×	240 0.7×	1.0k 3.2×	78 0.4×	159 0.9×	40	1.6k

Countries citing papers authored by Yingcheng Wu

Since Specialization

Citations

This map shows the geographic impact of Yingcheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingcheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingcheng Wu more than expected).

Fields of papers citing papers by Yingcheng Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingcheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingcheng Wu. The network helps show where Yingcheng Wu may publish in the future.

Co-authorship network of co-authors of Yingcheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingcheng Wu. A scholar is included among the top collaborators of Yingcheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingcheng Wu. Yingcheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Jiaomeng, Mao Zhang, Dongning Rao, et al.. (2025). CAD manipulates tumor intrinsic DHO/UBE4B/NF-κB pathway and fuels macrophage cross-talk, promoting HCC metastasis. Hepatology. 83(3). 451–465.

Wu, Yingcheng, Qiang Zou, Peng Jiang, & Qiang Gao. (2024). Tumor–Host Cometabolism Collaborates to Shape Cancer Immunity. Cancer Discovery. 14(4). 653–657. 10 indexed citations

Gao, Ke, Yin Li, Yingcheng Wu, et al.. (2024). ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma. Molecular & Cellular Proteomics. 23(9). 100821–100821. 4 indexed citations

Yang, Zijian, Cong Yan, Jiaqiang Ma, et al.. (2023). Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nature Metabolism. 5(1). 61–79. 354 indexed citations breakdown →

Wu, Yingcheng, Yifei Cheng, Xiangdong Wang, Jia Fan, & Qiang Gao. (2022). Spatial omics: Navigating to the golden era of cancer research. Clinical and Translational Medicine. 12(1). e696–e696. 84 indexed citations

Wu, Yingcheng, Tiancheng Zhang, Xiaoming Zhang, & Qiang Gao. (2022). Decoding the complexity of metastasis. Cancer Biology and Medicine. 19(3). 1–5. 6 indexed citations

Zhang, Han, et al.. (2022). Single-cell immune ecosystem and metabolism reprogramming imprinted by psoriasis niche. Annals of Translational Medicine. 10(15). 837–837. 13 indexed citations

Li, Yin, Yingcheng Wu, Liangqing Dong, et al.. (2022). FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling. Cellular Oncology. 46(1). 79–91. 13 indexed citations

Ni, Wenkai, Panpan Ma, Fengbo Zhao, et al.. (2021). The endoribonuclease N4BP1 prevents psoriasis by controlling both keratinocytes proliferation and neutrophil infiltration. Cell Death and Disease. 12(5). 488–488. 15 indexed citations

10.

Wu, Yingcheng, Yang Yang, Baorui Tao, et al.. (2020). Multi‐omics analysis reveals the functional transcription and potential translation of enhancers. International Journal of Cancer. 147(8). 2210–2224. 11 indexed citations

11.

Jin, Dandan, Jie Ji, Wei Jiang, et al.. (2020). Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis. PeerJ. 8. e9301–e9301. 13 indexed citations

12.

Wu, Yingcheng, Baorui Tao, Rong Sun, et al.. (2020). Super-enhancers modulate interleukin-6 expression and function in cancers. Translational Cancer Research. 9(9). 5555–5565. 2 indexed citations

13.

Wu, Yingcheng, Baorui Tao, Tianyang Zhang, Yihui Fan, & Renfang Mao. (2019). Pan-Cancer Analysis Reveals Disrupted Circadian Clock Associates With T Cell Exhaustion. Frontiers in Immunology. 10. 2451–2451. 85 indexed citations

14.

Jia, Keren, Yingcheng Wu, Liyang Wang, et al.. (2019). The identification of gene signature and critical pathway associated with childhood-onset type 2 diabetes. PeerJ. 7. e6343–e6343. 6 indexed citations

15.

Jia, Keren, et al.. (2019). Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma. Frontiers in Oncology. 9. 1317–1317. 6 indexed citations

16.

Wu, Yingcheng, Jinhuan Wei, Xia Chen, et al.. (2018). Comprehensive transcriptome profiling in elderly cancer patients reveals aging‐altered immune cells and immune checkpoints. International Journal of Cancer. 144(7). 1657–1663. 24 indexed citations

17.

Wu, Yingcheng, Qianqian Ju, Keren Jia, et al.. (2018). Correlation between sex and efficacy of immune checkpoint inhibitors (PD‐1 and CTLA‐4 inhibitors). International Journal of Cancer. 143(1). 45–51. 88 indexed citations

18.

Wu, Yingcheng, Jinhuan Wei, Ming Yue, et al.. (2018). Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma. Journal of Cellular Biochemistry. 119(9). 7696–7706. 14 indexed citations

19.

Wu, Yingcheng, Hui Shi, Maorong Jiang, et al.. (2017). The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta‐analysis of efficacy and safety. International Journal of Cancer. 141(12). 2562–2570. 36 indexed citations

20.

Wu, Yingcheng, Ran Xu, Keren Jia, & Hui Shi. (2017). The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysis. PLoS ONE. 12(11). e0187902–e0187902. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact